High levels of CD14+CD204+ cells in the pulmonary vein (PV) of patients with NSCLC were identified in cases of early recurrence and were positively related to the expression of CD204 in the tumor stroma of 207 stage I lung adenocarcinoma patients from Japanese cohort (178). This evidence concerns the gene MSR1 and lung adenocarcinoma.